Stalevo 100 and Cuts and puncture wounds - a phase IV clinical study of FDA data
Cuts and puncture wounds is reported only by a few people who take Stalevo 100.
The phase IV clinical study analyzes which people take Stalevo 100 and have Cuts and puncture wounds. It is created by eHealthMe based on reports of 3,018 people who have side effects while taking Stalevo 100 from the FDA, and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
3,018 people reported to have side effects when taking Stalevo 100.
Among them, 2 people (0.07%) have Cuts and puncture wounds.
What is Stalevo 100?
Stalevo 100 has active ingredients of carbidopa; entacapone; levodopa. It is often used in parkinson's disease. eHealthMe is studying from 3,086 Stalevo 100 users for its effectiveness, alternative drugs and more.
What is Cuts and puncture wounds?
Cuts and puncture wounds is found to be associated with 2,322 drugs and 1,765 conditions by eHealthMe.
Number of Stalevo 100 and Cuts and puncture wounds reports submitted per year:
Gender of people who have Cuts and puncture wounds when taking Stalevo 100 *:
- female: 50 %
- male: 50 %
Age of people who have Cuts and puncture wounds when taking Stalevo 100 *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs people take besides Stalevo 100 *:
- Sinemet: 1 person, 50.00%
- Pradaxa: 1 person, 50.00%
- Fish Oil: 1 person, 50.00%
- Ambien: 1 person, 50.00%
Common side effects people have besides Cuts and puncture wounds *:
- Fall: 2 people, 100.00%
- Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 50.00%
- Depression: 1 person, 50.00%
Common conditions people have *:
- Sleep Disorder: 1 person, 50.00%
- Insomnia (sleeplessness): 1 person, 50.00%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Stalevo 100 and have Cuts and puncture wounds?Check whether Cuts and puncture wounds is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Stalevo 100:
- Stalevo 100 (3,086 reports)
Cuts and puncture wounds treatments and more:
- Cuts and puncture wounds (15,850 reports)
COVID vaccines that are related to Cuts and puncture wounds:
- Cuts and puncture wounds in Moderna COVID Vaccine
- Cuts and puncture wounds in Pfizer BioNTech Covid Vaccine
- Cuts and puncture wounds in Johnson and Johnson Covid Vaccine
How severe was Cuts and puncture wounds and when was it recovered:
Expand to all the drugs that have ingredients of carbidopa; entacapone; levodopa:
Common drugs associated with Cuts and puncture wounds:
All the drugs that are associated with Cuts and puncture wounds:
- Cuts and puncture wounds (2,322 drugs)
Common conditions associated with Cuts and puncture wounds:
All the conditions that are associated with Cuts and puncture wounds:
- Cuts and puncture wounds (1,765 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on carbidopa; entacapone; levodopa (the active ingredients of Stalevo 100) and Stalevo 100 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.